Maria Luisa
Lozano Almela
Catedraticos de Universidad Vinculados
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Clínico San Carlos de Madrid (6)
2024
-
Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice
Blood, Vol. 144, Núm. 6, pp. 646-656
-
Thrombotic risk and features of patients with inferior vena cava agenesis: a multicentre, retrospective, observational study
The Lancet Haematology, Vol. 11, Núm. 8, pp. e606-e616
2022
-
Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays
Blood, Vol. 140, Núm. 2, pp. 140-151
2021
-
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients
Blood Cells, Molecules, and Diseases, Vol. 86
-
Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia (Scientific Reports, (2019), 9, 1, (16680), 10.1038/s41598-019-53209-y)
Scientific Reports